Form 4: Global Medical REIT Executive Buys Shares
Insider Transaction (Form 4)
Matthew Fitzsimmons Whitlock, Chief Investment Officer of Global Medical REIT Inc., purchased 1,000 shares of common stock on August 14, 2026.
Summary
- Open-market purchase: acquired 500 Common Stock at $37.21 ($18,605) on August 14, 2026; holds 1,500 after (Direct).
- Open-market purchase: acquired 500 Common Stock at $36.38 ($18,190) on August 17, 2026; holds 2,000 after (Direct).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $36,795, committing personal capital to the stock.
Insider Transactions
Matthew Fitzsimmons Whitlock — Officer (Chief Investment Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-14 | Open-market purchase | Common Stock | 500 | $37 | $18.6K | 1,500 |
| 2026-08-17 | Open-market purchase | Common Stock | 500 | $36 | $18.2K | 2,000 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-14 | Open-market purchase (500 shares) |
| 2026-08-17 | Open-market purchase (500 shares) |
Keywords
insider transaction, Form 4, XRN, Chiron Real Estate Inc., bullish, Matthew Fitzsimmons Whitlock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.